Follow the DISC MEDICINE INC stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €3.1bn. The latest transaction was disclosed on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN QUISEL. Every trade is accessible without an account.
Analysts rate DISC MEDICINE INC Strong Buy (bullish), based on 12 analysts. Average price target: US$101.58.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
DISC Medicine Inc es una empresa centrada en el desarrollo de terapias innovadoras para enfermedades relacionadas con la salud mental. Cotiza en NASDAQ bajo el ticker XNAS.